Page last updated: 2024-11-04
gatifloxacin and Infections, Salmonella
gatifloxacin has been researched along with Infections, Salmonella in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever." | 9.12 | An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. ( Arjyal, A; Basnyat, B; Campbell, JI; Dangol, S; Day, JN; Dolecek, C; Farrar, JJ; Pandit, A; Paudyal, B; Stepniewska, K; Yadav, B; Zimmerman, MD, 2007) |
| "To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever." | 5.12 | An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. ( Arjyal, A; Basnyat, B; Campbell, JI; Dangol, S; Day, JN; Dolecek, C; Farrar, JJ; Pandit, A; Paudyal, B; Stepniewska, K; Yadav, B; Zimmerman, MD, 2007) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Pandit, A | 1 |
| Arjyal, A | 1 |
| Day, JN | 1 |
| Paudyal, B | 1 |
| Dangol, S | 1 |
| Zimmerman, MD | 1 |
| Yadav, B | 1 |
| Stepniewska, K | 1 |
| Campbell, JI | 1 |
| Dolecek, C | 1 |
| Farrar, JJ | 1 |
| Basnyat, B | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Parallel Group, Double Blinded, 1:1, Randomized Controlled Phase III Trial of Co-trimoxazole Versus Azithromycin for the Treatment of Undifferentiated Fever In Nepal[NCT02773407] | Phase 3 | 330 participants (Actual) | Interventional | 2016-05-23 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for gatifloxacin and Infections, Salmonella